Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19649525 | 1.00 | ALDH1A1 (0.34) | ALDH1A1NPSR1MAPTHPGDKMT2A | |
| SCHEMBL14458137 | 0.77 | ALDH1A1 (0.33) | ALDH1A1NPSR1MAPTHPGDKMT2A | |
| SCHEMBL5606210 | 0.77 | ALDH1A1 (0.33) | ALDH1A1NPSR1MAPTHPGDKMT2A | |
| SCHEMBL6557553 | 0.77 | ALDH1A1 (0.33) | ALDH1A1NPSR1MAPTHPGDKMT2A | |
| SCHEMBL11177204 | 0.77 | CCNA2 (0.34) | ALDH1A1NPSR1MAPTHPGDKMT2A | |
| SCHEMBL11217640 | 0.76 | ALDH1A1 (0.33) | ALDH1A1MAPTTSHRLMNAKDM4E | |
| SCHEMBL1713453 | 0.72 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDKMT2ATSHR | |
| SCHEMBL31711467 | 0.72 | NR3C1 (0.32) | ALDH1A1MAPTHPGDKMT2ALMNA | |
| SCHEMBL10651665 | 0.72 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDKMT2ATSHR | |
| SCHEMBL11159606 | 0.70 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247752-B2 | Stereoselectively reducing 2,6,6-trimethyl-2-cyclohexene-1,4-dione with an optically active chiral catalyst to form an optically active hydroxycyclohexenone, contacting the product with a reducing agent to form an optically active diol, and using the diol to form astaxanthin | CARDAX PHARMACEUTICALS, INC. (US) | 2007-07-24 | — | — | US | disclosed |